Case Report: Metreleptin Treatment in a Patient With a Novel Mutation for Familial Partial Lipodystrophy Type 3, Presenting With Uncontrolled Diabetes and Insulin Resistance

BACKGROUND: Familial partial lipodystrophy type 3 (FPLD3) is a very rare autosomal dominant genetic disorder which is caused by mutations in the peroxisome proliferator activated receptor gamma (PPARG) gene. It is characterized by a partial loss of adipose tissue leading to subnormal leptin secretio...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Front Endocrinol (Lausanne)
Hlavní autoři: Lambadiari, Vaia, Kountouri, Aikaterini, Maratou, Eirini, Liatis, Stavros, Dimitriadis, George D., Karpe, Fredrik
Médium: Artigo
Jazyk:Inglês
Vydáno: Frontiers Media S.A. 2021
Témata:
Endocrinology
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8217860/
https://ncbi.nlm.nih.gov/pubmed/34168618
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fendo.2021.684182
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky